Armata Pharmaceuticals Inc (ARMP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,916 | -21,516 | -16,035 | -25,021 | -69,045 |
| Depreciation Amortization | 1,325 | 945 | 632 | 317 | 972 |
| Other Working Capital | -2,099 | -3,288 | -2,353 | -1,692 | -9,646 |
| Other Operating Activity | -17,861 | -5,765 | -3,005 | 15,812 | 30,296 |
| Operating Cash Flow | $-37,551 | $-29,624 | $-20,761 | $-10,584 | $-47,423 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,879 | -1,956 | -1,616 | -250 | -8,134 |
| Investing Cash Flow | $-1,879 | $-1,956 | $-1,616 | $-250 | $-8,134 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 34,889 | 34,889 | 34,889 | 34,889 | 54,026 |
| Common Stock Issued | 130 | 130 | 130 | 42 | 5 |
| Other Financing Activity | -61 | -61 | 0 | 0 | -43 |
| Financing Cash Flow | $34,958 | $34,958 | $35,019 | $34,931 | $53,988 |
| Beginning Cash Position | 19,243 | 19,243 | 19,243 | 19,243 | 20,812 |
| End Cash Position | 14,771 | 22,621 | 31,885 | 43,340 | 19,243 |
| Net Cash Flow | $-4,472 | $3,378 | $12,642 | $24,097 | $-1,569 |
| Free Cash Flow | |||||
| Operating Cash Flow | -37,551 | -29,624 | -20,761 | -10,584 | -47,423 |
| Capital Expenditure | -1,879 | -1,956 | -1,616 | -250 | -8,144 |
| Free Cash Flow | -39,430 | -31,580 | -22,377 | -10,834 | -55,567 |